Genmab | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Almirall EUR 146.82M 197.04M 2024-12
Amarin USD 36.9M 1.64M 2024-09
Amgen USD 1.69B 191M 2025-03
argenx SE USD 276.25M 9.7M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bayer EUR 3.71B 628M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Demant DKK 5.63B 2.77B 2024-12
Exelixis USD 137.18M 2.86M 2025-04
Fresenius Medical Care EUR 751M 89M 2025-03
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 126M 1.12B 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
GN Store Nord DKK 1.52B 99M 2025-03
GRIFOLS EUR 324.65M 55.17M 2025-03
Hikma Pharmaceutical USD 280M 4M 2024-06
Insmed USD 147.54M 5.03M 2025-03
Merck EUR 1.05B 361M 2024-12
Novartis USD 3.5B 368M 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06



Genmab Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.